Companion Medical announced last week it’s expanding access to its InPen™ System which will now be available in retail pharmacies nationwide.
Providers will now have the ability to e-prescribe InPen through their EMR directly to pharmacies. Companion has partnered with a leading pharmacy co-pay assistance company to provide financial assistance to those with commercial insurance, ensuring that InPen users pay no more than $99 annually, while most InPen users pay $50 or less for InPen per year.
“Our priority is to make InPen easy to prescribe and affordable to users,” said Sean Saint, Companion’s chief executive officer.
InPen accepts prefilled cartridges of both NovoLog and Humalog insulin and is covered on most prescription plans.
The company will be expanding its San Diego headquarters and sales territories to provide additional capacity for its growing commercial activities.
“Building a new diabetes product category is exciting and we’ve engaged a team of industry leaders to help drive awareness and adoption for InPen,” said Steve Lamar, director of marketing. “Companion leads the smart insulin pen market, and we continue to innovate rapidly to expand our feature set and product offerings.”
Featured Image: Companion Medical.
- Companion Medical Announces Expansion of Commercial Operations. PR Newswire. (2019, April 11). Retrieved: https://prnmedia.prnewswire.com/news-releases/companion-medical-announces-expansion-of-commercial-operations-300830663.html